Hedge funds are not perfect. They have their bad picks just like everyone else. Facebook, a stock hedge funds have loved dearly, lost nearly 40% of its value at one point in 2018. Although hedge funds ...
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F ...
Midwood Capital Management explained recent Recro Pharma (NASDAQ:REPH) stock price fluctuations in its Q1 2019 Investor Letter. If you are interested you can find a copy of the letter here. The fund ...
Recro Pharma, Inc. REPH has been struggling lately, but the selling pressure may be coming to an end soon. That is because REPH recently saw a Hammer Chart Pattern which can signal that the stock is ...
Recro Pharma, Inc. REPH was a big mover last session, as the company saw its shares rise nearly 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal ...
Sidney D. “Sid” Reph, 66, of 4338 Freemansburg Ave., Bethlehem, died Monday, Nov. 19, in his home. He was the husband of Joyce H. (Yeakel) Reph. They were married for 47 years last November. He was a ...
As of late, it has definitely been a great time to be an investor in Recro Pharma, Inc. ( REPH). The stock has moved higher by 18.6% in the past month, while it is also above its 20 Day SMA too. This ...
Recro Pharma (REPH) came out with a quarterly loss of $0.64 per share versus the Zacks Consensus Estimate of a loss of $0.67. This compares to loss of $0.48 per share a year ago. These figures are ...
Hedge funds are not perfect. They have their bad picks just like everyone else. Facebook, a stock hedge funds have loved dearly, lost nearly 40% of its value at one point in 2018. Although hedge funds ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results